• English
  • Deutsch
  • Log In
    Password Login
    Research Outputs
    Fundings & Projects
    Researchers
    Institutes
    Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Scopus
  4. Validation of the Symptomatic Dermographism Quality of Life Questionnaire (SD-QoL)
 
  • Details
  • Full
Options
2026
Journal Article
Title

Validation of the Symptomatic Dermographism Quality of Life Questionnaire (SD-QoL)

Abstract
Background: Symptomatic dermographism (SD) is the most common subtype of chronic inducible urticaria. It is characterized by the recurrent appearance of itch and subsequent strip-shaped wheals induced by applying shear forces on the skin, such as stroking or rubbing. The impossibility to avoid symptom's occurrence in most cases leads to a marked quality-of-life (QoL) impairment. As of yet, a validated and disease-specific instrument to adequately assess QoL in patients with SD is not available.
Objective: To validate the first disease-specific patient-reported outcome measure to assess health-related QoL impairment in patients with SD, the Symptomatic Dermographism Quality-of-Life Questionnaire (SD-QoL).
Methods: A 13-item QoL questionnaire had been previously generated and published. Now, the SD-QoL was analyzed regarding its domain structure and tested for its reliability and validity by evaluating its internal consistency, test-retest reliability, and convergent and known-groups validity.
Results: In total, 106 patients with SD participated in the SD-QoL validation study. The results suggest a 3-domain structure ("symptoms," "functioning," and "emotions"/"appearance") with an excellent internal consistency of the domains as well as the overall instrument. Furthermore, the analyses indicated high levels of convergent validity and known-groups validity as well as an excellent test-retest reliability.
Conclusions: The SD-QoL is the first validated disease-specific QoL instrument for SD that allows assessing QoL of patients with SD in clinical trials as well as in routine patient care.
Author(s)
Munoz Roldan, Melba Lucia
Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP  
Salameh, Pascale
Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP  
Altrichter, Sabine
Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP  
Durner, Leslie
Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP  
Geppert-Steidl, Clara
Johannes Gutenberg-Universität Mainz
Staubach, Petra
Johannes Gutenberg-Universität Mainz
Bernstein, Jonathan A.
University of Cincinnati College of Medicine
Weller, Karsten
Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP  
Journal
The journal of allergy and clinical immunology. In practice  
Open Access
File(s)
Download (2.26 MB)
Rights
CC BY 4.0: Creative Commons Attribution
DOI
10.1016/j.jaip.2025.10.002
10.24406/publica-7522
Additional link
Full text
Language
English
Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP  
Keyword(s)
  • Itch

  • Measure

  • Patient-reported outcome

  • Quality of life

  • Reliability

  • Symptomatic dermographism

  • Urticaria

  • Validation

  • Validity

  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Contact
© 2024